Skip to main content

Table 3 Anthropometric measurements (PP) at different control times (T1 baseline and, T5, T9, T13) in groups treated with polyglucosamine and orlistat

From: Randomised, double-blind, clinical investigation to compare orlistat 60 milligram and a customized polyglucosamine, two treatment methods for the management of overweight and obesity

Variable Group T1a T4a T9a T13a
Weight (kg) polyglucosamine 100.9 ± 13.44 97.2 ± 12.61 95.4 ± 12.79 94.1 ± 13.41
orlistat 97.9 ± 11.55 95.1 ± 11.24 94.5 ± 11.98 93.1 ± 11.82
BMI (kg/m2) polyglucosamine 34.6 ± 3.69 33.4 ± 3.58 32.8 ± 3.50 32.3 ± 3.59
orlistat 34.7 ± 4.76 33.7 ± 4.60 33.4 ± 4.68 33.0 ± 4.63
WC (cm) polyglucosamine 113.4 ± 11.13 109.6 ± 12.10 107.4 ± 11.85 105.1 ± 11.98
orlistat 109.5 ± 10.13 106.8 ± 9.55 104.2 ± 9.30 103.4 ± 9.14
  1. aThe differences between groups are not statistically significant (t test)
Back to article page

BMC Obesity

ISSN: 2052-9538

Contact us